PFE vs REX · P/E 20, rev $62.58B vs P/E 15, rev $642.5M
Pfizer Inc (PFE) versus REX American Resources Corporation (REX) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
REX American Resources Corporation (REX) is a chemicals company listed on NYSE.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported REX revenue for 2025-01-31 was $642.5M. Net income was $71.5M. Revenue was down 22.9% from 2024-01-31 to 2025-01-31. REX currently screens at market cap $1.43B and trailing P/E 15.5.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. REX currently screens at market cap $1.43B and trailing P/E 15.5.
Not investment advice. Open the PFE and REX stock pages for the full models.
Not investment advice.